跳至主要内容
临床试验/NCT01638455
NCT01638455已完成不适用

Noninvasive Parameter Testing With Pulse CO-Oximetry and Measurement of Blood Constituents With In-Vitro Analyzers

Masimo Corporation1 个研究点 分布在 1 个国家目标入组 2,776 人开始时间: 2012年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
2,776
试验地点
1

研究概览

简要总结

Characterize Masimo noninvasive technology in spot check reading on subjects and make comparison to invasive blood sampling tested on reference analyzers.

详细描述

Noninvasive readings from subjects done according to manufacturer's directions of use compared to simultaneously derived blood samples measured on in vitro analyzers

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other

入排标准

性别
All
接受健康志愿者
是

入选标准

  • •Male or female of any age ≥ 3 kg.
  • •Subjects may include healthy volunteers, outpatient or inpatient populations

排除标准

  • •Subjects with skin abnormalities at the planned application sites that may interfere with sensor application or trans-illumination of the site, such as burns, scar tissue, nail polish, acrylic nails, infections, etc.
  • •Subjects deemed not suitable for study at the discretion of the investigator

研究组 & 干预措施

Test Group

Experimental

All subjects will be enrolled in the test group and will receive the noninvasive device

干预措施: Noninvasive device (Device)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验